Building Trust, Enabling Precision
We empower comprehensive analyses of behavior and biology in neurodegenerative and neuropsychological disorders. Our patient-centric approach means our staff can routinely cultivate the trust needed to collect the diverse sample and data types needed for studying these complex diseases. As an end-to-end service solution provider, we streamline logistics to save you time and resources, while maximizing your project’s potential.
- Alzheimer’s Disease (AD)
- Amyotrophic Lateral Sclerosis (ALS)
- Attention Deficit Hyperactivity Disorder (ADHD)
- Bipolar Disorder
- Depression
- Epilepsy
- General Anxiety Disorder
- Insomnia
- Myasthenia Gravis
- Multiple Sclerosis
- Parkinson’s Disease (PD)
Sanguine's Expertise in Neurodegeneration & Neuropsychology
>1,500
Patient Members
>25
Studies Completed
Contact us to discuss your research needs
Sanguine Services
- Flare events
- Longitudinal
- "Multicohort--> Similar mechanism (e.g. diseases of the complement pathway)"
- PBMC isolation
- Urine processing
- Serum and plasma isolation
- Flare events (eg: Multiple sclerosis)
- Remission
- Active disease
- Stage (early, middle, late)
- Whole Blood
- Serum
- Plasma
- Urine
- Skin Taping
- DNA/RNA
- PBMCs (+ Derivatives)
- Hair
- Stool
- Semen
- Nails
- Buffy Coat
- Disease Confirmation
- Covid-19 (PCR)
- Sickle Cell
- HIV/HPV/Hepatitis/Herpes Etc.
- BioMarker Quantification
- CBC, Platelett, & Diff
- CRP
- Cal-Protecin
- ANA
- Cytokine Panel
- BUN
- Urinalysis
- Thyroid Stimulating Hormone
- Lipid Panel
- LDH
- Genetic Analysis
- HLA Typing
- dsDNA
- RNA Vial Load Qaunitification
- HBV Genotyping
- SLEDAI scoring
- CDAI (Crohn's)
- DAS-28 (RA)
- SF-36
- HAQ-DI
- FACIT
- Bristol Scoring
- PRO
- Medical Records
- Demographics
- DAS (spell out)
- ALSFER Score
The emergence of new experimental therapies suggests the pace of clinical advancement may finally increase for neurodegenerative and neuropsychological conditions. We offer a single point of access to a nationwide growing community of patients living with these conditions, reachable through our mobile fleet of phlebotomists. Our in-home capabilities include minimally invasive biospecimens and data collection, all sourced from highly annotated patients who routinely engage with us. Through direct relationships with them and their caregivers, we create new opportunities and unique perspectives for the pharmaceutical industry within this high-risk, high-reward field.
Hear From Our Community
Featured Publications
Subscribe to our Newsletter
Select what you would like to receive directly in your email